Cargando…
A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell Cytotoxicity
SIMPLE SUMMARY: The use of small compounds in cancer immunotherapy has been limited so far. Her we screen for drugs that enhanced the ability of immune cells to kill tumor cells and identified the molecule Colistin Sulfate as a booster of immune activity. ABSTRACT: Due to their crucial role in tumor...
Autores principales: | Cortés-Kaplan, Serena, Kurdieh, Reem, Hasim, Mohamed S., Kaczmarek, Shelby, Taha, Zaid, Maznyi, Glib, McComb, Scott, Lee, Seung-Hwan, Diallo, Jean-Simon, Ardolino, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221353/ https://www.ncbi.nlm.nih.gov/pubmed/35740500 http://dx.doi.org/10.3390/cancers14122832 |
Ejemplares similares
-
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
por: Alluqmani, Nouf, et al.
Publicado: (2022) -
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy
por: Wong, Boaz, et al.
Publicado: (2022) -
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023) -
Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022) -
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
por: Birdi, Harsimrat Kaur, et al.
Publicado: (2021)